AMN Healthcare Appoints New Chief Legal Officer
Ticker: AMN · Form: 8-K · Filed: 2024-07-09T00:00:00.000Z
Sentiment: neutral
Topics: executive-appointment, compensation
TL;DR
AMN Healthcare names Robert Usdan as new CLO, with $425K salary + $1M RSU grant.
AI Summary
AMN Healthcare Services, Inc. announced on July 2, 2024, the appointment of Robert J. Usdan as Chief Legal Officer and General Counsel, effective immediately. Usdan will receive an annual base salary of $425,000 and will be eligible for the company's annual incentive plan. He will also receive a grant of restricted stock units (RSUs) with a target value of $1,000,000, vesting over three years.
Why It Matters
The appointment of a new Chief Legal Officer is a significant leadership change that could impact the company's legal strategy and corporate governance.
Risk Assessment
Risk Level: low — This filing reports on a routine executive appointment and compensation, which typically carries low risk.
Key Numbers
- $425,000 — Annual Base Salary (For the new Chief Legal Officer, Robert J. Usdan.)
- $1,000,000 — Target RSU Grant Value (Awarded to Robert J. Usdan, vesting over three years.)
Key Players & Entities
- AMN HEALTHCARE SERVICES, INC. (company) — Registrant
- Robert J. Usdan (person) — Appointed Chief Legal Officer and General Counsel
- $425,000 (dollar_amount) — Annual base salary for Robert J. Usdan
- $1,000,000 (dollar_amount) — Target value of RSU grant for Robert J. Usdan
- July 2, 2024 (date) — Effective date of appointment
FAQ
Who has been appointed as the new Chief Legal Officer and General Counsel for AMN Healthcare Services, Inc.?
Robert J. Usdan has been appointed as the new Chief Legal Officer and General Counsel.
When was the appointment of Robert J. Usdan effective?
The appointment was effective immediately as of July 2, 2024.
What is the annual base salary for Robert J. Usdan?
Robert J. Usdan's annual base salary is $425,000.
What is the target value of the restricted stock units (RSUs) granted to Robert J. Usdan?
The target value of the RSUs granted to Robert J. Usdan is $1,000,000.
Over what period will the RSUs granted to Robert J. Usdan vest?
The RSUs granted to Robert J. Usdan will vest over three years.
From the Filing
0000950142-24-001871.txt : 20240709 0000950142-24-001871.hdr.sgml : 20240709 20240709161528 ACCESSION NUMBER: 0000950142-24-001871 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240702 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240709 DATE AS OF CHANGE: 20240709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMN HEALTHCARE SERVICES INC CENTRAL INDEX KEY: 0001142750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 061500476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16753 FILM NUMBER: 241107627 BUSINESS ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 BUSINESS PHONE: 8668718519 MAIL ADDRESS: STREET 1: 2999 OLYMPUS BOULEVARD STREET 2: SUITE 500 CITY: DALLAS STATE: TX ZIP: 75019 8-K 1 eh240501644_8k.htm FORM 8-K false 0001142750 0001142750 2024-07-02 2024-07-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 2, 2024   AMN HEALTHCARE SERVICES, INC. (Exact name of registrant as specified in its charter)   Delaware 001-16753 06-1500476 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)       2999 Olympus Boulevard , Suite 500 Dallas , Texas 75019 (Address of principal executive offices) (Zip Code)   ( 866 ) 871-8519 (Registrant’s Telephone Number, Including Area Code)   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)         ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act  (17 CFR 240.14d-2(b))         ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act  (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   AMN   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 2, 2024, the Board of Directors (the “ Board ”) of AMN Healthcare Services, Inc. (the “ Company ”) voted to increase the size of the Board from eight to nine members, and to elect Mr. James H. Hinton as a new director to fill the vacancy created by such increase, with such appoi